Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Arrowstreet Capital’s Top Picks Include Philip Morris International Inc. (PM), AstraZeneca plc (ADR) (AZN) & More

Arrowstreet Capital was founded by Peter Rathjens, Bruce Clarke, and John Campbell in 1999. With assets under management of over $25 billion, the hedge fund uses mathematical and statistical models as a strategy of picking stocks. Learn why it’s crucial to track top-tier hedge funds’ quarterly 13Fs.

GlaxoSmithKline plc (ADR) (NYSE:GSK)

Let’s get back to Arrowstreet. During the second quarter of 2013, the hedge fund disclosed its largest stake in GlaxoSmithKline plc (ADR) (NYSE:GSK). The stake includes 10.2 million shares and is worth more than $510.5 million. During the second quarter of 2013, the hedge fund increased its stake in GlaxoSmithKline plc (ADR) (NYSE:GSK) by 45% or about 3.2 million shares, which moved it one position up in the equity portfolio.

The second-largest pick in the Arrowstreet equity portfolio is Philip Morris International Inc. (NYSE:PM), in which the hedge fund holds 5.1 million shares, worth $441.2 million, up by 397,309 shares over the quarter. The stock of Philip Morris International Inc. (NYSE:PM) has returned over 5% since the beginning of the year, and sports a P/E of 17.0x.

In AstraZeneca plc (ADR) (NYSE:AZN), Arrowstreet Capital disclosed a $291.5 million position, up from $166 million reported at the end of the first three months of 2013. The stake contains about 6.2 million shares, up by over 2.8 million shares over the quarter. The healthcare company AstraZeneca plc (ADR) (NYSE:AZN) has a year-to-date return of above 8% and trades at a forward P/E of 10.2x.

Next on our list is DIRECTV (NASDAQ:DTV), represented in the hedge fund’s equity portfolio by 4.5 million shares, worth $279.5 million. In the previous 13F filing, Arrowstreet Capital reported a $317.8 million stake in DIRECTV (NASDAQ:DTV), which contained 5.6 million shares. With a forward P/E of about 10.8, the stock of DIRECTV (NASDAQ:DTV) returned almost 23.5%.

And the last but not the least, we should mention 17.6 million shares of Corning Incorporated (NYSE:GLW). The stake is worth $250.6 million, up from $216.3 million disclosed at the end of March, when the stake comprised 16.2 million shares. The stock of Corning Incorporated (NYSE:GLW) returned over 20% since January and has a forward P/E of 10.6x.

On the whole, the market value of Arrowstreet Capital’s equity portfolio amounts to $13.4 million, up from $12.4 million reported at the end of the first quarter of 2013, and it involves over 800 positions.

Richard Chilton’s Chilton Investment Company, Philippe Laffont’s Coatue Management and Quincy Lee’s Ancient Art (Teton Capital) are also worth taking a look at.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!